Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Business SupportHouse : Private

BSE418.004.45 (+1.08 %)

PREV CLOSE ( ) 413.55

OPEN PRICE ( ) 409.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 13255

TODAY'S LOW / HIGH ( )409.00 430.35

52 WK LOW / HIGH ( )372.5 902.85

NSE419.856.5 (+1.57 %)

PREV CLOSE( ) 413.35

OPEN PRICE ( ) 410.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 271414

TODAY'S LOW / HIGH( ) 406.10 431.00

52 WK LOW / HIGH ( )376.05 902.65

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-11 1990

Management Info

Sivalinga Prasad Vasireddi - Chairman Harita Vasireddi - Managing Director

Registered Office

Address Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District,
Hyderabad,
Telangana-500051

Phone 040- 27264141

Email shares@vimta.com

Website www.vimta.com

Registrars Details

Cil Securities Ltd

214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad

Listing : BSE, NSE

NEWS

23Feb Vimta Labs informs about analyst meet
Vimta Labs has informed that it enclosed intimation of Schedule of Analy..

30Sep Vimta Labs informs about trading windo
Vimta Labs has informed that the Trading Window for transactions in shar..

17Jul Vimta Labs informs about outcome of bo
Vimta Labs has informed that it enclosed Unaudited Financial Results as..

29Apr Vimta Labs gets nod for foray into bio
Vimta Labs has received approval for foray into biologics contract resea..

29Apr Vimta Labs gains on getting nod for fo
Vimta Labs is currently trading at Rs. 1038.00, up by 16.90 points or 1...

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	175.86	673.42
Gross Profit	233.71	890
Operating Profit	360.63	1261.89
Net Sales	986.33	3439.82

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Medi Assist Health (BSE) 342.00 (4.19%)	M.Cap ( in Cr)2537.62
Just Dial (BSE) 531.75 (2.43%)	M.Cap ( in Cr)4507.37
Awfis Space Solution (BSE) 281.35 (3.25%)	M.Cap ( in Cr)1987.04
Silicon Rental Solut (BSE) 108.30 (6.70%)	M.Cap ( in Cr)120.13
Indiqube Spaces (BSE) 149.00 (3.91%)	M.Cap ( in Cr)3158.76

Shareholding Pattern

	NON-INSTITUTION	59.41%
	PROMOTERS	35.9%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.05
Motilal Oswal BSE H...	0.05

Risk Disclosures on Derivatives

Smart Quotes

VIMTA LABS LTD.